MedPath

Perphenazine

Perphenazine Tablets, USP

Approved
Approval ID

ef44f1e9-0826-4670-9b98-8bdd2189b3c7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 23, 2019

Manufacturers
FDA

DOH CENTRAL PHARMACY

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Perphenazine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-1124
Application NumberANDA205973
Product Classification
M
Marketing Category
C73584
G
Generic Name
Perphenazine
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 23, 2019
FDA Product Classification

INGREDIENTS (10)

HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
PERPHENAZINEActive
Quantity: 2 mg in 1 1
Code: FTA7XXY4EZ
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Perphenazine - FDA Drug Approval Details